Polyanalgesic Consensus Conference-2012: Recommendations to Reduce Morbidity and Mortality in Intrathecal Drug Delivery in the Treatment of Chronic Pain.

Introduction:  Targeted intrathecal drug infusion to treat moderate to severe chronic pain has become a standard part of treatment algorithms when more conservative options fail. This therapy is well established in the literature, has shown efficacy, and is an important tool for the treatment of both cancer and noncancer pain; however, it has become clear in recent years that intrathecal drug delivery is associated with risks for serious morbidity and mortality. Methods:  The Polyanalgesic Consensus Conference is a meeting of experienced implanting physicians who strive to improve care in those receiving implantable devices. Employing data generated through an extensive literature search combined with clinical experience, this work group formulated recommendations regarding awareness, education, and mitigation of the morbidity and mortality associated with intrathecal therapy to establish best practices for targeted intrathecal drug delivery systems. Results:  Best practices for improved patient care and outcomes with targeted intrathecal infusion are recommended to minimize the risk of morbidity and mortality. Areas of focus include respiratory depression, infection, granuloma, device-related complications, endocrinopathies, and human error. Specific guidance is given with each of these issues and the general use of the therapy. Conclusions:  Targeted intrathecal drug delivery systems are associated with risks for morbidity and mortality that can be devastating. The panel has given guidance to treating physicians and healthcare providers to reduce the incidence of these problems and to improve outcomes when problems occur.

Hundreds of variants clustered in genomic loci and biological pathways affect human height.

Most common human traits and diseases have a polygenic pattern of inheritance: DNA sequence variants at many genetic loci influence the phenotype. Genome-wide association (GWA) studies have identified more than 600 variants associated with human traits, but these typically explain small fractions of phenotypic variation, raising questions about the use of further studies. Here, using 183,727 individuals, we show that hundreds of genetic variants, in at least 180 loci, influence adult height, a highly heritable and classic polygenic trait. The large number of loci reveals patterns with important implications for genetic studies of common human diseases and traits. First, the 180 loci are not random, but instead are enriched for genes that are connected in biological pathways (P = 0.016) and that underlie skeletal growth defects (P < 0.001). Second, the likely causal gene is often located near the most strongly associated variant: in 13 of 21 loci containing a known skeletal growth gene, that gene was closest to the associated variant. Third, at least 19 loci have multiple independently associated variants, suggesting that allelic heterogeneity is a frequent feature of polygenic traits, that comprehensive explorations of already-discovered loci should discover additional variants and that an appreciable fraction of associated loci may have been identified. Fourth, associated variants are enriched for likely functional effects on genes, being over-represented among variants that alter amino-acid structure of proteins and expression levels of nearby genes. Our data explain approximately 10% of the phenotypic variation in height, and we estimate that unidentified common variants of similar effect sizes would increase this figure to approximately 16% of phenotypic variation (approximately 20% of heritable variation). Although additional approaches are needed to dissect the genetic architecture of polygenic human traits fully, our findings indicate that GWA studies can identify large numbers of loci that implicate biologically relevant genes and pathways.

Un acte de guérilla : la pseudonymie en Afrique francophone subsaharienne

L'affirmation de soi à travers l'adoption d'un pseudonyme se présente comme une forme d'autocréation qui répond à l'acte d'écriture, en tant que forme première d'une individualité dans la langue. Le nouveau nom remplit la fonction symbolique d'invention de soi par la nomination, tout en jouant, chez certains écrivains d'Afrique noire, de l'inscription d'une autre langue au sein de l'onomastique française. Pour certains d'entre eux, l'autonomination apparaît même comme un acte de guérilla, une affirmation de soi et non une dissimulation, marquée au coin de l'onomastique africaine et d'un contexte historico-politique qui lui donne sens. Dans le cadre de cet article, à considérer comme l'esquisse d'une réflexion abordant un champ encore peu exploré, il s'agit d'envisager les divers enjeux de la nomination en Afrique noire, puis d'interroger les pratiques d'écrivains pseudonymes, tels Sony Labou Tansi, Mongo Beti et Ken Bugul, qui constituent des cas de figure particulièrement significatifs de cette pratique. Self-affirmation via the adoption of a pseudonym constitues a form of self-creation springing from the act of writing, in the guise of a primary shape given within language to an individual. The new name fulfills the symbolic function of inventing oneself through nomination while playing on - in the instance of certain black African writers - the inscription of another language within French onomastics. For one, self-naming appears as a « guerilla action », an affirmation of self and not its dissimulation, marked on the edges by African onomastics and an historico-political context that gives the meaning. In this article, offered as an outline of an approch to an little-explored field of investigation, we seek to identify the various stakes related to naming in black Africa, before examining specific techniques demonstrated by pseudonymous writers such as Sony Labou Tansi, Mongo Beti, and Ken Bugul, taken as exemplary and particulary significant in this domain.

Genome-wide association and functional follow-up reveals new loci for kidney function.

Chronic kidney disease (CKD) is an important public health problem with a genetic component. We performed genome-wide association studies in up to 130,600 European ancestry participants overall, and stratified for key CKD risk factors. We uncovered 6 new loci in association with estimated glomerular filtration rate (eGFR), the primary clinical measure of CKD, in or near MPPED2, DDX1, SLC47A1, CDK12, CASP9, and INO80. Morpholino knockdown of mpped2 and casp9 in zebrafish embryos revealed podocyte and tubular abnormalities with altered dextran clearance, suggesting a role for these genes in renal function. By providing new insights into genes that regulate renal function, these results could further our understanding of the pathogenesis of CKD.

Atomic force microscopy of nucleoprotein complexes.

Recent data on the AFM studies of nucleoprotein complexes of different types are reviewed in this paper. The first section describes the progress in the sample preparation methods for AFM studies of nucleic acids and nucleoprotein complexes. The second part of this paper reviews AFM data on studies of complexes of DNA with regulatory proteins. These studies include two different types of DNA distortion induced by proteins binding: local bending of DNA at sites of protein binding and formation of large loops due to protein-protein interactions between molecules bound to distant sites along the DNA molecules (DNA looping). The prospects for use of AFM for physical mapping of genomes are discussed in this section as well. The third part of the paper reviews data on studies of complexes of DNA with non-sequence specific binding proteins. Special emphasis is given to studies of chromatin which have resulted in progress in the understanding of structure of native chromatin fiber. In this section, novel data on AFM studies of RecA-DNA filaments and complexes of dsRNA with the dsRNA-specific protein p25 are also presented. Discussion of the substrate preparation procedures in relation to the AFM studies of nucleoprotein complexes is given in the final section.

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution.

To identify genetic loci influencing central obesity and fat distribution, we performed a meta-analysis of 16 genome-wide association studies (GWAS, N = 38,580) informative for adult waist circumference (WC) and waist-hip ratio (WHR). We selected 26 SNPs for follow-up, for which the evidence of association with measures of central adiposity (WC and/or WHR) was strong and disproportionate to that for overall adiposity or height. Follow-up studies in a maximum of 70,689 individuals identified two loci strongly associated with measures of central adiposity; these map near TFAP2B (WC, P = 1.9x10(-11)) and MSRA (WC, P = 8.9x10(-9)). A third locus, near LYPLAL1, was associated with WHR in women only (P = 2.6x10(-8)). The variants near TFAP2B appear to influence central adiposity through an effect on overall obesity/fat-mass, whereas LYPLAL1 displays a strong female-only association with fat distribution. By focusing on anthropometric measures of central obesity and fat distribution, we have identified three loci implicated in the regulation of human adiposity.

FTO genotype is associated with phenotypic variability of body mass index.

There is evidence across several species for genetic control of phenotypic variation of complex traits, such that the variance among phenotypes is genotype dependent. Understanding genetic control of variability is important in evolutionary biology, agricultural selection programmes and human medicine, yet for complex traits, no individual genetic variants associated with variance, as opposed to the mean, have been identified. Here we perform a meta-analysis of genome-wide association studies of phenotypic variation using ∼170,000 samples on height and body mass index (BMI) in human populations. We report evidence that the single nucleotide polymorphism (SNP) rs7202116 at the FTO gene locus, which is known to be associated with obesity (as measured by mean BMI for each rs7202116 genotype), is also associated with phenotypic variability. We show that the results are not due to scale effects or other artefacts, and find no other experiment-wise significant evidence for effects on variability, either at loci other than FTO for BMI or at any locus for height. The difference in variance for BMI among individuals with opposite homozygous genotypes at the FTO locus is approximately 7%, corresponding to a difference of ∼0.5 kilograms in the standard deviation of weight. Our results indicate that genetic variants can be discovered that are associated with variability, and that between-person variability in obesity can partly be explained by the genotype at the FTO locus. The results are consistent with reported FTO by environment interactions for BMI, possibly mediated by DNA methylation. Our BMI results for other SNPs and our height results for all SNPs suggest that most genetic variants, including those that influence mean height or mean BMI, are not associated with phenotypic variance, or that their effects on variability are too small to detect even with samples sizes greater than 100,000.

Common variants near MC4R are associated with fat mass, weight and risk of obesity.

To identify common variants influencing body mass index (BMI), we analyzed genome-wide association data from 16,876 individuals of European descent. After previously reported variants in FTO, the strongest association signal (rs17782313, P = 2.9 x 10(-6)) mapped 188 kb downstream of MC4R (melanocortin-4 receptor), mutations of which are the leading cause of monogenic severe childhood-onset obesity. We confirmed the BMI association in 60,352 adults (per-allele effect = 0.05 Z-score units; P = 2.8 x 10(-15)) and 5,988 children aged 7-11 (0.13 Z-score units; P = 1.5 x 10(-8)). In case-control analyses (n = 10,583), the odds for severe childhood obesity reached 1.30 (P = 8.0 x 10(-11)). Furthermore, we observed overtransmission of the risk allele to obese offspring in 660 families (P (pedigree disequilibrium test average; PDT-avg) = 2.4 x 10(-4)). The SNP location and patterns of phenotypic associations are consistent with effects mediated through altered MC4R function. Our findings establish that common variants near MC4R influence fat mass, weight and obesity risk at the population level and reinforce the need for large-scale data integration to identify variants influencing continuous biomedical traits.

Coeficiente de determinação genotípica e de diversidade genética em topocruzamentos de soja tipo alimento com tipo grão

As estimativas do coeficiente de herdabilidade são importantes para a escolha de uma estratégia eficaz de seleção. Quando os tratamentos são considerados fixos, a herdabilidade é denominada coeficiente de determinação genotípica. Os objetivos do presente trabalho foram estimar, através de topocruzamentos obtidos entre soja tipo alimento e soja tipo grão, o coeficiente de determinação genotípica e avaliar a diversidade genética de modo a se distinguir diferenças de contribuição dos parentais de soja tipo alimento com sementes grandes e com sementes pequenas usados nos topocruzamentos, assim como avaliar a interação de cada grupo com o ambiente. Os resultados de determinação genotípica obtidos nas médias de topocruzamentos foram: 90,51% com relação ao número de dias para maturidade (NDM); 93,92% com relação à altura da planta na maturidade (APM); 79,52% com relação ao acamamento (AC); 91,37% ao valor agronômico (VA); 95,55% ao peso de cem sementes (PCS); 57,57% à produtividade de grãos (PG), e 91,18% à largura visual das vagens (LVV), enquadrando-se aos valores encontrados na literatura. Em relação às estimativas de diversidade genética, que representam a disponibilidade de diferenças genéticas para seleção, os caracteres NDM, APM e AC apresentaram valores maiores nos topocruzamentos envolvendo parentais exóticos de sementes pequenas e para VA, PCS, PG e LVV nos topocruzamentos envolvendo parentais exóticos de sementes grandes.

Correlações fenotípicas entre tamanho de grãos e outros caracteres em topocruzamentos de soja tipo alimento com tipo grão

Este trabalho foi conduzido para avaliar a correlação fenotípica entre vários caracteres em topocruzamentos entre soja tipo alimento e soja tipo grão (Doko e FT-2). Valores de interesse para facilitar a seleção foram obtidos nas correlações entre peso de cem sementes (tamanho de sementes) e dias para atingir a maturidade, e entre tamanho de sementes e largura visual da vagem. Na correlação entre produtividade de grãos e tamanho de sementes somente os topocruzamentos com Doko foram significativos. As estimativas de correlações em plantas individuais tenderam a confirmar aquelas obtidas em médias de parcelas. Os valores de correlação foram diferentes entre os tipos (grão, broto/"natto" e hortaliça) de soja envolvidos, o que sugere a adoção de estratégias de seleção distintas. O estudo de correlações para cada topocruzamento é importante, pois podem ocorrer diferenças no desempenho das plantas como foi observado nos resultados obtidos.

Poxvirus vector-based HIV vaccines.

PURPOSE OF REVIEW: In this review, we will provide the scientific rationale for the use of poxvirus vectors in the field of HIV vaccines, the immunological profile of the vaccine-induced immune responses, an update on the current use of poxvirus vector-based vaccines in HIV vaccine clinical trials, and the development of new modified poxvirus vectors with improved immunological profile. RECENT FINDINGS: An Ad5-HIV vaccine was tested in a phase IIb clinical trial (known as the Step trial). Vaccinations in the Step trial were discontinued because the vaccine did not show any effect on acquisition of infection and on viral load. After the disappointing failure of the Step trial, the field of HIV vaccine has regained enthusiasm and vigour due to the promising protective effect observed in the phase III efficacy trial (known as RV-144) performed in Thailand which has tested a poxvirus-gp120 combination. SUMMARY: The RV-144 phase III has provided for the first time evidence that an HIV vaccine can prevent HIV infection. The results from the RV-144 trial are providing the scientific rationale for the future development of the HIV vaccine field and for designing future efficacy trials.